APONTIS PHARMA AG revenue breakdown overview

APONTIS PHARMA AG revenue for the last year amounted to 37.00 M EUR, the most of which — 25.64 M EUR — came from its highest performing source at the moment, Single Pills - Hypertension, the year earlier bringing 36.54 M EUR. The greatest contribution to the revenue figure was made by Germany — last year it brought APONTIS PHARMA AG 36.96 M EUR, and the year before that — 55.73 M EUR.